glp 1 agonist classification Overview of GLP-1 Receptor Agonists Available in the United States for GLP-1 Agonists Explained: Definition, How

Indications: FDA approved: Type II diabetes - monotherapy or combination therapy Can be combined as adjunct therapy with other hypoglycemics including metformin, thiazolidinediones, or insulin regimens (Dungan & DeSantis 2015) Because it does not work when your blood sugar is low, it is unlikely to produce dangerous levels of hypoglycemia has been observed in clinical trials (in contrast to GLP-1 incretin mimetics, such as exenatide, which produce moderate weight loss)

The use of GLP-1 RAs for these conditions is still off-label , and the literature lacks clear guidelines on the appropriate drug management in these clinical uses [8]

These medications combine the effects of a GLP-1 receptor agonist with an agonist for GIP, another hormone produced by the small intestine

Circulation 127, 7485

Neuropsychopharmacology 43 , 627637, (2018)